IL 3625
Pill imprint IL 3625 has been identified as Theophylline extended-release 300 mg.
Theophylline is used in the treatment of asthma, maintenance; apnea of prematurity; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy.
Theophylline 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Theophylline extended-release Images
- Imprint:
-
IL
3625 - Strength:
- 300 mg
- Color:
- White / Clear
- Size:
- 17.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- ferric oxide black
butylparaben
castor oil
edetate calcium disodium
ethylcellulose
gelatin
methylparaben
pharmaceutical glaze
povidone
propylparaben
sodium lauryl sulfate
sodium propionate
starch
sugar spheres
magnesium silicate
titanium dioxide
- Drug Class:
- Methylxanthines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Inwood Laboratories Inc.
- National Drug Code (NDC):
- 00258-3625
Advertisement
More Theophylline Extended-Release resources
- Theophylline (Wolters Kluwer)
- Theophylline Elixir (Wolters Kluwer)
- Theophylline Sustained-Release Capsules (Wolters Kluwer)
- Theophylline Sustained-Release Tablets (Wolters Kluwer)
- theophylline (Cerner Multum)
- Norphyl (Micromedex) - Includes Dosage Information
- Phyllocontin (Micromedex) - Includes Dosage Information
- theophylline (Micromedex) - Includes Dosage Information
- theophylline Intravenous (Micromedex) - Includes Dosage Information
- Theophylline (FDA)
- Theophylline Elixir (FDA)
- Theophylline Oral Solution (FDA)
- Theophylline in Dextrose (FDA)
- Theophylline (Wolters Kluwer)
Search Again
